Coding Tip: Anticoagulation and Antiplatelet Therapy
Kim Carrier RHIT, CDIP, CCS, CCS-P
Director of Coding Quality Assurance
AHIMA Approved ICD-10-CM/PCS Trainer
Anticoagulation and Antiplatelet Therapy
Anticoagulants and antiplatelets are used for the prevention and treatment of blood clots that occur in blood vessels. Oftentimes, anticoagulants and antiplatelets are referred to as “blood thinners,” but they don’t actually thin the blood at all. These drugs slow down the body’s process of making clots. Their main function is to keep the patient’s blood from clotting or turning into solid clumps of cells. These drugs do this by interfering with either fibrin or platelets in the blood.
Blood clots consist of two main components:
- Fibrin is a protein substance that is formed from fibrinogen, which is a soluble protein that in synthesized in the liver and found in the blood plasma. This enables the blood to clot. Blood must clot (hemostasis) in order to stop bleeding from injury or diseases that lead to hemorrhage/bleeding. Anticoagulants inhibit the creation of fibrin.
- Platelets are cells within our blood that bind together to help the blood clot. Their main function is to stop us from bleeding to death. When the body is bleeding a signal is sent and the platelets respond by traveling to the area of the bleeding. Once they have arrived at the site of the hemorrhage, they grow long tentacles and resemble spiders or an octopus when viewed under a microscope. Before they are signaled for clotting, they are plate shaped. Antiplatelets prevent platelets from sticking together.
Fun Fact! Clots that are formed in the vein are mostly made of fibrin. This includes the diagnoses that we see of deep-vein-thrombosis (DVT). However, clots in the arteries typically are formed with mostly platelets. This includes the arterial diagnoses we see such as arterial thrombus, brain thrombus and heart thrombus, to name a few.
Most Common Anticoagulant Drugs:
- Eliquis (apixaban)
- Coumadin (warfarin)
- Xarelto (rivaroxaban)
- Pradaxa (dabigatran)
- Bevyxxa (betrixaban)
- Savaysa (edoxaban)
Most Common Antiplatelet Drugs:
- Plavix (clopidogrel)
- Effient (prasugrel)
- Brillinta (ticagrelor)
- Aggrenox (dipyridamole/ASA)
For coding professionals, it is important to pick up the long-term current use of both anticoagulants and antiplatelets, and report with the appropriate ICD-10-CM diagnosis code. Taking these medications can require further labs, monitoring or testing.
Z 79.01—Long-term Current use of anticoagulant (see above for most common)
Z79.02—Long-term Current use of antiplatelet (see above for most common)
Z79.82—Long-term Current use of aspirin (aspirin has its’ own code)
How long does it take for anticoagulants to dissolve a blood clot?
This is a trick question! Anticoagulants do NOT dissolve blood clots. They only help prevent new clots from occurring, or existing clots from enlarging, but they do not aid in dissolving the old clot. The body will dissolve the clot naturally if it can be dissolved.
The length for taking these medications depends on the reason for needing to start them in the first place. They can prescribed for a few weeks or for the rest of your life. The site of the blood clot (if that is why they are prescribed) also helps to determine the length the medication will be needed.
Most Common Reasons Prescribed:
- Blood clots or people that are at high risk for developing one
- Pulmonary embolism
- Atrial fibrillation
- Heart attack/previous heart attack/acute coronary syndrome/angina
- Heart disease/cardiomyopathy
- Presence of coronary stent
- Post-surgical heart
- Post-surgical vascular system
- Peripheral vascular disease
Are there risks involved with taking anticoagulants and antiplatelets?
There are always risk to any medication and treatment, but the physician will weigh out the risk vs. benefit before starting the patient on either of these medications. The risk vs. benefit of prescribing an anticoagulant/antiplatelet is a very serious thought process. If the patient has a risk of falls or frequent falls, the decision may be to NOT begin the patient on an anticoagulant or antiplatelet. The chance of increased bleeding is very high in a patient on anticoagulants. Hemorrhage is the most concerning adverse effect of the medication in a patient on anticoagulants.
Signs & Symptoms to Look for:
- Bleeding from nose or gums
- Large bruises (especially if it forms a lump)
- Pink or red colored urine
- Blood in stool (dark red or black stool)
- Vomiting blood or coffee ground looking material
- Lack of clotting with a minor injury within an expected amount of time
- Coughing up blood
- Heavy periods
Remember for coding, if the patient is taking their medication as prescribed and develops an adverse reaction, such as bleeding, this is coded as an adverse reaction to the prescribed medication and not a poisoning. If the patient is NOT taking the medication as prescribed and hemorrhage or other issue occurs, this is coded as a poisoning.
The latest edition of AHA, Coding Clinic for ICD-10-CM/ICD-10-PCS has given direction to coders on reporting the diagnosis of traumatic head injury associated with enhanced bleeding due to patient’s Coumadin use.
Per the recent AHA Coding Clinic this is reported with the trauma code followed by the codes for hemorrhagic disorder due to extrinsic circulating anticoagulants along with the adverse effect of medication, and long term (current) use of anticoagulants. The example that is given is a patient with a subdural hemorrhage that is enhanced due to the patient’s use of Coumadin therapy. A Question that comes to mind for coders in cases like this is “is the bleeding due to the fall or the medications?” If it is not clear, a query will be needed for the physician to determine if this was due to trauma…like a cause and effect. Only the physician can make these decisions. It could be that the injury is not severe enough to have caused the subdural hemorrhage with only minor external injury and the subdural hemorrhage caused the fall. Since we can’t make assumptions, the physician will need to clarify if it is not clearly stated in the record.
ICD-10-CM/PCS Coding Clinic, First Quarter ICD-10 2021 Page: 4
ICD-10-CM Official Guidelines for Coding and Reporting FY 2021
The information contained in this coding advice is valid at the time of posting. Viewers are encouraged to research subsequent official guidance in the areas associated with the topic as they can change rapidly.
In Part 4 of the series, we will review the NTAP procedure codes and reimbursement add-on payments. Prepare yourself as this is rather lengthy due to continuation of NTAP that would normally expire.
Coders are instructed, at this time, to follow the AHA Frequently Asked Questions Regarding ICD-10-CM/PCS Coding for COVID-19. Lately, we have seen missing PCS codes for the new technology drugs that were introduced on August 1, 2020 and thereafter.
With the creation and implementation of ICD-10-CM, multiple codes are available to describe the type of pulmonary emboli that occur.
Hypercoagulable states are blood disorders that increase the risk of deep vein thrombosis or embolic disease. The state is either inherited or acquired. About 80% of patients with blood clots have been found to have either an inherited or acquired clotting disorder. These blood clots can be lethal and some require life-long therapy. Hypercoagulable state is also known as thrombophilia.
Encephalopathy is a general term and means brain disease, brain damage or malfunction. Physicians often use encephalopathy and altered mental status interchangeably. When coders see this documentation in the healthcare records, they typically need to query the physician for clarification of the diagnosis.
Spinal procedure coding can be daunting for coders. The spine itself can be quite complicated anatomically and the procedures done to address spinal conditions can be even more complicated!
In June CMS released the final ICD-10-PCS codes for FY2022, which begins October 1, 2021. We are giving you a sneak peek at the changes. HIA will have a full educational module on these changes available later this summer.
CMS released the IPPS proposed rule on 4/27/21 outlining the proposed changes to the Inpatient Prospective Payment System for FY2022, which begins October 1, 2021. Later this year, sometime in August, CMS will release the Final Rule. Currently CMS is reviewing responses to their proposed rule and will address them in the final rule.
A medical coding audit is a process that includes internal or external reviews of medical coding and billing accuracy, procedures or policies in place, and any other component that affects the medical record documentation. Medical coding audits…
Carotid artery disease is a vague category that can incorporate many different carotid artery issues. Some physicians may feel that they are being clear the patient has plaque, stenosis, or occlusion of the artery, but in ICD-10-CM the specificity must be included in the documentation.
10 ICD-10 Codes for Superheroes. Superman: T78.2XXA Anaphylactic reaction; substance: kryptonite. Batman: F44.81 Dissociative identity disorder. Robin: F60.7 dependent personality. The Hulk: L30.4 Erythema intertrigo. Wonder Woman: T24.032A Burn of unspecified degree of left lower leg. Black Panther S93.401A Sprain…
Practices have not seen many revisions to the Evaluation and Management (E/M) office / outpatient visit guidelines in three decades – until now. As of January 1, there are new E/M coding guidelines. We’ll get to those in a bit, but first let’s look at why they changed.
Pseudoseizures are a form of non-epileptic seizure. These are difficult to diagnose and oftentimes extremely difficult for the patient to comprehend. The term “pseudoseizures” is an older term that is still used today to describe psychogenic nonepileptic seizures (PNES).
With the implementation of ICD-10-CM came different codes and coding rules for many diagnoses. One of these is the coding of bowel obstruction when the patient presents for this condition that is caused by another condition.
This is Part 5 of a five part series on the new 2021 CPT codes. For the remaining areas we will just briefly summarize the section. Due to the intricate nature of these sections in CPT, it is recommended that the coder read the entire section notes associated with the new codes.
This is Part 4 of a five part series on the new 2021 CPT codes. In this series we will explore the CPT changes in the urinary, nervous, ocular and auditory systems. There are 2 new urinary/male reproductive system codes with no revisions or deletions; 3 new female reproductive codes with 2 deletions, 0 new with 4 deleted nervous system codes with 5 revisions; 5 new eye category III codes; and finally a 2 new auditory codes with one deletion.
This is Part 3 of a five part series on the new 2021 CPT codes. In this series we will explore the cardiovascular system CPT changes. There are 5 new cardiovascular CPT codes added with 0 deletions and 4 revisions.
This is Part 2 of a five part series on the new 2021 CPT codes. In this series we will explore the CPT changes for FY2021 and include some examples to help the coder understand the new codes. There are 0 new musculoskeletal CPT codes added with 0 deletions and 2 major revisions along with an extensive update to arthroscopic loose body removal requirements. For the respiratory system, there were 2 new codes, one code deletion and no revisions.
This is Part 1 of a five part series on the new 2021 CPT codes. In this series we will explore the CPT changes for FY2021 and include examples to help the coder understand the new codes. For 2021 in general, there were 199 new CPT codes added, 54 deleted and 69 revised.
In January, new CPT codes were released. There were 248 new CPT codes added, 71 deleted and 75 revised. Most of the surgery section changes were in the musculoskeletal and cardiovascular subsections. These included procedures such as skin grafting, breast biopsies, deep drug delivery systems, tricuspid valve repairs, aortic grafts and repair of iliac artery.
In the previous three parts of this four-part series, we discussed the new ICD-10-CM diagnosis code changes, ICD-10-PCS procedure code changes and FY2021 IPPS changes. In this last Part 4 of the series, we will review the NTAP procedure codes and reimbursement add-on payments for FY2021.
In the previous two parts of this four part series, we discussed the new ICD-10-CM diagnosis code changes and ICD-10-PC procedure code changes. In this session we will review the major IPPS changes for FY2021.
This is Part 2 of a 4 part series on the FY2021 ICD-10 Code and IPPS changes. In this part, the ICD-10-PCS procedure codes are presented. For FY2021 ICD-10-PCS there are 78,115 total codes (FY2020 total was 77,571); 556 new codes (734 new last year in FY2020)…
This is Part 1 of a 4 part series on the FY2021 changes to ICD-10 and the IPPS. In this part, we discuss some of the new ICD-10-CM diagnosis changes. Here is the breakdown: 72,616 total ICD-10-CM codes for FY2021; 490 new codes (2020 had 273 new codes); 58 deleted codes (2020 had 21 deleted codes); 47 revised codes (2020 had 30 revised codes)
Acute pulmonary edema is the rapid accumulation of fluid within the tissue and space around the air sacs of the lung (lung interstitium). When this fluid collects in the air sacs in the lungs it is difficult to breathe. Acute pulmonary edema occurs suddenly and is life threatening.
“Client S” is a small, not-for-profit, 40 bed micro-hospital in the Southeast. HIA performed a 65-record review this year for Client S and found an opportunity with 15 of them. 9 had an increased reimbursement with a total of $43,228 found.